Supplementary Data from A Somatostatin Receptor Subtype-3 (SST<sub>3</sub>) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors

This supplementary file contains supplementary methods (library screening and statistical analysis) and table S1 (Pharmacological characterization of SST3-selective compounds), table S2 (Relation of functional experiments performed in responsive (RP) and unresponsive (URP) NFPTs), table S3 (Percentage of responsive and unresponsive NFPTs regarding SST3-specific agonists in terms of cell viability), table S4 (Results from Chi-square test of clinical parameters between responsive and unresponsive NFPTs), and table S5 (Clinical data and SST3 mRNA expression levels of individual NFPTs).